PATENT CLAIM ANALYSIS

Application Number: 15895023
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-07
Patent Classification: ["514", "04400A"]

Abstract:
The invention relates to methods of inhibiting the expression of a PCSK9 gene in a subject, as well as therapeutic and prophylactic methods for treating subjects having a lipid disorder, such as a hyperlipidemia using RNAi agents, e.g., double-stranded RNAi agents, targeting the PCSK9 gene.

Claim (Index 17):
The method of  claim 15 , wherein the additional therapeutic agent is an anti-PCSK9 antibody.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 88.0
- Lexical Diversity: 1.45714
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14650128', '15313145', '15591532', '15591558', '15221651']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8270051869453909
- 35 USC 102 Novelty (BERT): 0.5589345397089245
- Combined Prediction Score: 0.8001981222217442
- Mean Citation Score: 419.934062
- Max Citation Score: 509.76566
- Similarity Product: 294.10122223826284

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test